168 related articles for article (PubMed ID: 7654933)
21. Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitution.
Borrell M; Vila L; Solá J; Coll I; Fontcuberta J
Haemostasis; 1990; 20(1):1-7. PubMed ID: 2323678
[TBL] [Abstract][Full Text] [Related]
22. Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala----Thr.
Koopman J; Haverkate F; Lord ST; Grimbergen J; Mannucci PM
J Clin Invest; 1992 Jul; 90(1):238-44. PubMed ID: 1634610
[TBL] [Abstract][Full Text] [Related]
23. Fibrinogen Lima. A new dysfibrinogenaemia with a high-molecular-weight alpha-chain and effective polymerization.
Arocha-Piñango CL; Rodriguez S; Nagy H; Perez Requejo JL
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):561-5. PubMed ID: 2133234
[TBL] [Abstract][Full Text] [Related]
24. Fibrinogen Oviedo I. A new Spanish dysfibrinogenaemia.
Fernández FJ; Rodríguez Pinto C; Páramo J; Cuesta B; Collado M; Rocha E
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):571-5. PubMed ID: 2133236
[TBL] [Abstract][Full Text] [Related]
25. Two novel mutations in the fibrinogen γ nodule.
Kotlín R; Pastva O; Stikarová J; Hlaváčková A; Suttnar J; Chrastinová L; Riedel T; Salaj P; Dyr JE
Thromb Res; 2014 Oct; 134(4):901-8. PubMed ID: 25074738
[TBL] [Abstract][Full Text] [Related]
26. Fibrinogen anomalies and disease. A clinical update.
Galanakis DK
Hematol Oncol Clin North Am; 1992 Oct; 6(5):1171-87. PubMed ID: 1400080
[TBL] [Abstract][Full Text] [Related]
27. Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization.
Lee MH; Kaczmarek E; Chin DT; Oda A; McIntosh S; Bauer KA; Clyne LP; McDonagh J
Blood; 1991 Oct; 78(7):1744-52. PubMed ID: 1912564
[TBL] [Abstract][Full Text] [Related]
28. Gene analyses of abnormal fibrinogens with a mutation in the gamma chain.
Mimuro J; Muramatsu S; Maekawa H; Sakata Y; Kaneko M; Yoshitake S; Okuma M; Ito Y; Takeda Y; Matsuda M
Int J Hematol; 1992 Oct; 56(2):129-34. PubMed ID: 1421174
[TBL] [Abstract][Full Text] [Related]
29. Fibrinogen Matsumoto II: gamma 308 Asn-->Lys (AAT-->AAG) mutation associated with bleeding tendency.
Okumura N; Furihata K; Terasawa F; Ishikawa S; Ueno I; Katsuyama T
Br J Haematol; 1996 Sep; 94(3):526-8. PubMed ID: 8790154
[TBL] [Abstract][Full Text] [Related]
30. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
Okumura N; Furihata K; Terasawa F; Nakagoshi R; Ueno I; Katsuyama T
Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
[TBL] [Abstract][Full Text] [Related]
31. Fibrinogen Guarenas I: partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization.
Lundberg UG; Rodriguez S; Marchi R; Ruiz-Saez A; Arocha-Piñango CL
Thromb Res; 1995 Apr; 78(2):95-106. PubMed ID: 7482436
[TBL] [Abstract][Full Text] [Related]
32. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release.
Mathonnet F; Guillon L; Detruit H; Mazmanian GM; Dreyfus M; Alvarez JC; Giudicelli Y; de Mazancourt P
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754
[TBL] [Abstract][Full Text] [Related]
33. Fibrinogen Bern I: substitution gamma 337 Asn-->Lys is responsible for defective fibrin monomer polymerization.
Steinmann C; Reber P; Jungo M; Lämmle B; Heinemann G; Wermuth B; Furlan M
Blood; 1993 Oct; 82(7):2104-8. PubMed ID: 8400260
[TBL] [Abstract][Full Text] [Related]
34. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).
Mosesson MW; Siebenlist KR; DiOrio JP; Matsuda M; Hainfeld JF; Wall JS
J Clin Invest; 1995 Aug; 96(2):1053-8. PubMed ID: 7635941
[TBL] [Abstract][Full Text] [Related]
35. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II).
Kamijyo Y; Hirota-Kawadobora M; Yamauchi K; Terasawa F; Honda T; Ikeya M; Okumura N
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):726-32. PubMed ID: 19809304
[TBL] [Abstract][Full Text] [Related]
36. Normal plasmic cleavage of the gamma-chain variant of "fibrinogen Saga" with an Arg-275 to His substitution.
Yamazumi K; Terukina S; Onohara S; Matsuda M
Thromb Haemost; 1988 Dec; 60(3):476-80. PubMed ID: 2976995
[TBL] [Abstract][Full Text] [Related]
37. Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia.
Reber P; Furlan M; Henschen A; Kaudewitz H; Barbui T; Hilgard P; Nenci GG; Berrettini M; Beck EA
Thromb Haemost; 1986 Dec; 56(3):401-6. PubMed ID: 3563970
[TBL] [Abstract][Full Text] [Related]
38. A novel fibrinogen variant (fibrinogen Seoul II; AalphaGln328Pro) characterized by impaired fibrin alpha-chain cross-linking.
Park R; Doh HJ; An SS; Choi JR; Chung KH; Song KS
Blood; 2006 Sep; 108(6):1919-24. PubMed ID: 16735602
[TBL] [Abstract][Full Text] [Related]
39. Fibrinogen Cordoba I: A gammaArg 275 His substitution associated with defective polymerization.
Guglielmone HA; Minoldo S; Jarchum GD; Daga DA; Bocco JL
Thromb Res; 2007; 121(3):429-30. PubMed ID: 17604827
[No Abstract] [Full Text] [Related]
40. [Functional study of abnormal fibrinogen caused by Arg275His mutation in fibrinogen γ chain].
Zhou JY; Wang XF; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):190-4. PubMed ID: 23683413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]